openPR Logo
Press release

Influenza B Infection Market Trends and Forecast 2017 - 2025 : Humabs BioMed SA, ContraFect Corporation, and Takeda Pharmaceutical Company Limited

02-04-2019 12:09 PM CET | Health & Medicine

Press release from: TMR Research

Influenza B Infection Market Trends and Forecast 2017 - 2025 :

Global Influenza B Infection Market: Snapshot

Influenza B infection is considered as one of the common conditions that affects a large number of people across the globe, caused due to the influenza virus B genera of the family. The condition of influenza B infection requires proper medications and treatments in order to avoid severe complications. At present, several medicines and vaccinations are made available in order to reduce the incidence of influenza B infection across the globe. The increasing number of initiatives taken governments and NGOs to create an awareness among people regarding this condition is projected to accelerate the growth of the global market in the next few years.

The prominent players operating in the global influenza B infection market are focusing on the development and new and effective therapeutics so as to reach a large number of patients across the globe. This is projected to offer promising growth opportunities in the next few years. In addition, the increasing expenditure on the development of the healthcare facilities, especially in developing economies are likely to accelerate the growth of the global influenza B infection market in the coming few years.

The presence of a huge number of players in the global market with a strong drug pipeline and the rising emphasis on clinical trials are estimated to develop the competitive scenario of the global influenza B infection market in the coming years. Moreover, the easy availability of drugs is predicted to supplement the growth of the overall market in the near future. With these factors, the global market for influenza B infection is projected to experience a high growth over the forecast period.

Request Sample Copy of the Report @

https://www.tmrresearch.com/sample/sample?flag=B&rep_id=290

Global Influenza B Infection Market: Overview

Influenza is commonly classified as type A, B, or C, depending on the protein composition of the virus. Influenza B infection is caused by influenzavirus B genera of the family Orthomyxoviridae and is found only in humans. Common symptoms of the infection include runny nose, chills, fever, muscle pain, sore throat, fatigue, coughing, and general weakness. Nausea and vomiting is also observed in some cases, particularly in children. Frequent hand washing, wearing masks to prevent transmission, routine annual vaccination, and practicing good respiratory hygiene are the few ways that can help reduce the risk of people catching the infection. Vaccination offers a good protection against influenza B infection and is also important for people in high risk regions.

Global Influenza B Infection Market: Scope of Diagnostics

Symptoms of the infection if not treated on time may lead to complications such as bacterial pneumonia, myositis, encephalitis, Reyes’ syndrome, and sinus and ear infections. The infection is transmitted via air, by sneezing or coughing. Children are highly susceptible to the influenza B infection though it is also known to affect a substantial number of adults. Influenza B virus can be further broken down into different strains and lineages. Currently, two lineages identified include B/Victoria/2/87-like and B/Yamagata/16/88-like. Diagnosis of the infection is generally carried out by observing the symptoms. Laboratory testing is recommended in certain cases such as influenza outbreak and patients with high risk of complications.

Request TOC of the Report @

https://www.tmrresearch.com/sample/sample?flag=T&rep_id=290

Global Influenza B Infection Market: Core Segmentations

The global influenza B infections market can be segmented based on drug class, pipeline assessment and geography. Histopathological examinations help in assessing airway, and tissues of lung, heart, and lymph node for determining influenze B infection. Various molecules under pipeline for treating influenza B infections are BTL- TML001, favipiravir, and CR-9114. The World Health Organization (WHO) and the U.S. Center for Disease Control and Prevention recommend influenza vaccines for individuals with high risk such as healthcare workers, the elderly population, children and people suffering from chronic diseases such as diabetes, asthmatics, and heart disorder patients. Influenza vaccines are commonly administered as injection or nasal spray.

Antiviral drugs of class M2 protein inhibitors such as adamantine derivatives and neuraminidase inhibitors including zanamivir and oseltamivir are generally used to treat the infection. Zanamivir and oseltamivir help shorten the duration of the infection and also lower the risk of development of additional complications, though these drugs cause mild side-effects such as nausea and vomiting. Recent studies suggest that antiviral drugs such as amantadine and rimantadine are no longer effective due to generation of resistance by influenza virus. Home remedies include fluid intake, rest and over-the-counter painkillers. Acetaminophen helps in relieving headache, muscle ache and fever. However, aspirin is contraindicated since it increases the risk of Reyes’ syndrome. Antibiotics are recommended only in cases of bacterial complications and are also known to cause side effects and development of antibiotic resistance. Various other alternative treatments include homeopathic and herbal medicines though their safety and efficacy is yet under evaluation.

Read Comprehensive Overview of Report @

https://www.tmrresearch.com/influenza-b-infection-market

Global Influenza B Infection Market: Competitive Landscape

Geographically, the global influenza B infection market can be categorized into North America, Europe, Asia Pacific and Rest of the World. Yearly, approximately 200,000 people in the U.S. need to be hospitalized due to complications related to flu.

Some of the key players contributing to the global influenza B infections market have been AltraVax, Inc., Autoimmune Technologies, LLC, Crucell N.V., Chimerix, Inc., REPLICor, Inc., Humabs BioMed SA, ContraFect Corporation, and Takeda Pharmaceutical Company Limited.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza B Infection Market Trends and Forecast 2017 - 2025 : Humabs BioMed SA, ContraFect Corporation, and Takeda Pharmaceutical Company Limited here

News-ID: 1556696 • Views:

More Releases from TMR Research

Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - 2031
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030. The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2021 to 2031.
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030. The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Growing Regions like North America, Europe and Asia Pacific.
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot  Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about